OBI Pharma, Inc. (TPEX:4174)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
-0.10 (-0.31%)
Apr 29, 2026, 1:30 PM CST

OBI Pharma Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
759.331,732899.284,7412,512
Upgrade
Short-Term Investments
4271,3991,88330.71140
Upgrade
Trading Asset Securities
-0.090.230.751.77
Upgrade
Cash & Short-Term Investments
1,1863,1312,7824,7732,654
Upgrade
Cash Growth
-62.11%12.53%-41.70%79.83%-28.69%
Upgrade
Accounts Receivable
12.714.26.482.043.47
Upgrade
Other Receivables
307.4246.34225.8626.2419.8
Upgrade
Receivables
320.11250.54232.3428.2723.27
Upgrade
Inventory
18.4327.7325.9321.979.56
Upgrade
Prepaid Expenses
55.2230.6826.38211.26167.35
Upgrade
Other Current Assets
--100.34--
Upgrade
Total Current Assets
1,5803,4403,1675,0342,854
Upgrade
Property, Plant & Equipment
994.291,1651,2491,1761,149
Upgrade
Long-Term Investments
747.34946.951,0708.739.11
Upgrade
Goodwill
---61.1561.15
Upgrade
Other Intangible Assets
46.8662.8473.18321.29337.14
Upgrade
Other Long-Term Assets
52.6939.0351.6432.976.21
Upgrade
Total Assets
3,4215,6545,6116,6344,487
Upgrade
Accounts Payable
0.993.440.771.140.53
Upgrade
Accrued Expenses
92.18251.965.76112.49177.82
Upgrade
Short-Term Debt
50.350.414.3115.71-
Upgrade
Current Portion of Long-Term Debt
71.8734.09777
Upgrade
Current Portion of Leases
54.0255.1249.8640.3552.07
Upgrade
Current Income Taxes Payable
2.4610.391.580.560.34
Upgrade
Current Unearned Revenue
2.297.786.293.16-
Upgrade
Other Current Liabilities
76.449.2430.2840.7389.47
Upgrade
Total Current Liabilities
350.56412.37165.84221.14327.22
Upgrade
Long-Term Debt
29.4648.2260.0667.0728
Upgrade
Long-Term Leases
309.98366.79425.89163.03205.96
Upgrade
Long-Term Deferred Tax Liabilities
---46.3354.76
Upgrade
Other Long-Term Liabilities
6.146.015.890-
Upgrade
Total Liabilities
696.13833.39657.67497.57615.95
Upgrade
Common Stock
1,3162,6322,2942,2941,993
Upgrade
Additional Paid-In Capital
--7,1286,9333,702
Upgrade
Retained Earnings
-8,616-7,879-5,569-4,523-2,909
Upgrade
Treasury Stock
--26.53-26.53-45.99-45.99
Upgrade
Comprehensive Income & Other
9,1899,089-19.87-26.32-24.53
Upgrade
Total Common Equity
1,8893,8153,8074,6322,716
Upgrade
Minority Interest
836.581,0061,1471,5041,155
Upgrade
Shareholders' Equity
2,7254,8204,9536,1363,871
Upgrade
Total Liabilities & Equity
3,4215,6545,6116,6344,487
Upgrade
Total Debt
515.68504.63547.11293.15293.03
Upgrade
Net Cash (Debt)
670.652,6262,2354,4792,361
Upgrade
Net Cash Growth
-74.46%17.49%-50.10%89.73%-32.08%
Upgrade
Net Cash Per Share
5.1022.4819.5240.3323.73
Upgrade
Filing Date Shares Outstanding
131.58131.48114.62114.5599.47
Upgrade
Total Common Shares Outstanding
131.58131.48114.62114.5599.47
Upgrade
Working Capital
1,2303,0273,0014,8132,527
Upgrade
Book Value Per Share
14.3529.0133.2140.4427.30
Upgrade
Tangible Book Value
1,8423,7523,7344,2502,318
Upgrade
Tangible Book Value Per Share
14.0028.5332.5737.1023.30
Upgrade
Land
---87.5187.51
Upgrade
Buildings
344.49344.49343.2370.02329.28
Upgrade
Machinery
1,0611,0801,0221,054671.26
Upgrade
Construction In Progress
1.6510.0766.4635.74368.45
Upgrade
Leasehold Improvements
265.97276.85181.24184.0665.85
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.